Search Results 1721-1730 of 21448 for platelets

1. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Platelet count < 100,000 per mm3. Patients with any of the following serum chemistry abnormalities at baseline: Total bilirubin > 1.5× the ULN for the ...

2. Precision Ventilation Vs Standard Care For Acute Respiratory Distress Syndrome - Mayo Clinic

   Ongoing severe coagulopathy (platelet \< 5000/μL or INR \> 4) 6. Extracorporeal membrane oxygenation (ECMO) or CO2 removal (ECCO2R) 7. Neuromuscular disease ...

3. Autologous DC Vaccine For RRP Patients - Mayo Clinic

   Platelet count (PLT) ≥ 75 x 109 /L ...

4. Pain Medicine - Overview - Mayo Clinic

   The field of regenerative therapies is growing rapidly and includes treatments such as platelet-rich plasma and stem cell injections. The combination of ...

5. Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer - Mayo Clinic

   Platelet (PLT) ≥ 100,000; Hemoglobin (HgB) > 10.0; Creatinine ≤ 1.5 x upper limit of normal (ULN). Exclusion Criteria: Pre-existing history of peripheral ...

6. Publications - Paul M. Scholten, M.D. - Mayo Clinic

   ... platelet-rich plasma injection: a case report. PM R. 2015 Jan; 7 (1):79-83 Epub 2014 Aug 16. View PubMed; Scholten PM, Ng KW, Joh K, Serino LP, Warren RF ...

7. Knee pain - Diagnosis and treatment - Mayo Clinic

   Platelet-rich plasma (PRP). PRP contains a concentration of many different growth factors that appear to reduce inflammation and promote healing. Some ...

8. A Study Comparing Combination Chemotherapy to Gemcitabine Hydrochloride and Nab-Paclitaxel Given Before Surgery for Treating Patients who have Pancreatic Cancer that can be Removed by Surgery - Mayo Clinic

   Platelets ≥ 100,000/mcL; Hemoglobin ≥ 9 g/dL; Total bilirubin ≤ 1.5 x institutional upper limit of normal (IULN); Aspartate aminotransferase (AST) and ...

9. Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer - Mayo Clinic

   Platelets ≥ 100,000/mm3;; Bilirubin ≤ 1.5 x institutional upper limit of normal (ULN);; AST (SGOT)/ALT (SGPT) < 2.5 X institutional upper limit of normal ...

10. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    Platelets (PLT) >= 100,000/mm^3; Lymphocytes >= 700/mm^3; Hemoglobin >= 10 g/dL; Total bilirubin =< 1.5 X upper limit of normal (ULN) unless history of ...